Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas
Top Cited Papers
- 1 February 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (3) , 636
- https://doi.org/10.1200/jco.2000.18.3.636
Abstract
PURPOSE: A recent report suggests that alterations of chromosome arms 1p and 19q are associated with chemotherapeutic response and overall survival in anaplastic oligodendroglioma patients treated ...Keywords
This publication has 31 references indexed in Scilit:
- Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtypeOncogene, 1999
- Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic OligodendrogliomasJNCI Journal of the National Cancer Institute, 1998
- Pathologic diagnosis as the gold standardCancer, 1997
- Procarbazine, lomustine, and vincristine (PCV) chemotherapy for Grade III and Grade IV oligoastrocytomasJournal of Neurosurgery, 1996
- Low-grade oligodendroglioma responds to chemotherapyNeurology, 1996
- Region‐specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human gliomaGenes, Chromosomes and Cancer, 1995
- Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.Journal of Clinical Oncology, 1994
- Deletion mapping of chromosome 19 in human gliomasInternational Journal of Cancer, 1994
- The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapyJournal of Neurosurgery, 1992
- Successful chemotherapy for recurrent malignant oligodendrogliomaAnnals of Neurology, 1988